BB

Babita Bhol

Director DIN 06573489
DIN 06573489 First appointment Jul 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Babita Bhol

Data last updated:

Babita Bhol was an Additional Director at Pristine Biomedical Private Limited (from 2013) and Director at Shree Sairaj Biotech Private Limited (from 2014).

DIN 06573489
First Appointment 04 Jul 2013
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pristine Biomedical Private Limited U51507DL2010PTC199434
Additional Director04 Jul 20132010Strike Off
Shree Sairaj Biotech Private Limited U24200DL2014PTC262955
Director01 Jan 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pristine Biomedical Private Limited
Shree Sairaj Biotech Private Limited
Premium access

Shareholding and investment profile for Babita Bhol

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babita Bhol

Babita Bhol was first appointed on 04 Jul 2013 as Additional Director at Pristine Biomedical Private Limited. The most recent appointment on record is 01 Jan 2014 at Shree Sairaj Biotech Private Limited.

Babita Bhol held 2 earlier board appointments: Pristine Biomedical Private Limited (Additional Director, from 04 Jul 2013); Shree Sairaj Biotech Private Limited (Director, from 01 Jan 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available